13 studies on Kisspeptin receptor agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights Kisspeptin's potential as a therapeutic agent for mitigating the adverse effects of maternal hypothyroidism on pregnancy outcomes. The restoration of placental mTOR signaling and glucose homeo…
This study provides crucial human data, indicating that an acute intravenous bolus of kisspeptin 112-121 at the tested dose is not effective as a provocative diagnostic test for AVP-D. This finding refines our underst…
This research highlights the Kisspeptin/GPR54 axis as a novel and promising therapeutic target for PAH, a disease with limited effective treatments. By restoring mitochondrial function and normalizing mitophagy in PAS…
Understanding how the HPG axis responds to stimulation like Kisspeptin-10 across different age groups is crucial for addressing age-related reproductive health issues. This research provides foundational insights into…
While this specific study did not yield results, the initial intent highlights the potential scientific interest in Kisspeptin-10 as a modulator of insulin secretion. If future research successfully demonstrates a rol…
Understanding the interplay between reproductive hormones like kisspeptin and metabolic processes could open new avenues for treating metabolic diseases. If kisspeptin were found to positively influence insulin secret…